Quality of life in patients with congestive heart failure and central sleep apnea

被引:34
作者
Carmona-Bernal, Carmen [1 ]
Ruiz-Garcia, Aranzazu [1 ]
Villa-Gil, Manuel [2 ]
Sanchez-Armengol, Angeles [1 ]
Quintana-Gallego, Esther [1 ]
Ortega-Ruiz, Francisco [1 ]
Baron-Esquivias, Gonzalo [2 ]
Capote, Francisco [1 ]
机构
[1] Univ Hosp Virgen Rocio, Resp Dis Med Surg Unit, Seville, Spain
[2] Univ Hosp Virgen Rocio, Dept Cardiol, Seville, Spain
关键词
congestive heart failure; central sleep apnea; Minnesota living with heart failure questionnaire; functional outcomes of sleep questionnaire;
D O I
10.1016/j.sleep.2007.11.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess the impact of Cheyne-Stoke respiration-central sleep apnea (CSR-CSA) on quality of life (QOL) in patients with congestive heart failure (CHF). QOL was established using the MLHFQ (Minnesota Living with Heart Failure Questionnaire), and the FOSQ (Functional Outcomes of Sleep Questionnaire). Methods: We examined 90 patients with CHF. The diagnosis of CSR-CSA was performed by polysonmography. We established a correlation between the apnea-hypopnea index (AHI) and the MLHFQ and FOSQ scores. Results: Five patients were excluded (obstructive sleep apnea). Of the 85 remaining patients, 25 presented CSR-CSA. The mean MLHFQ score was higher in patients with CHF and CSR-CSA (25.8 +/- 2.97 vs. 16.6 +/- 2.05; p = 0.01), and showed a significant yet moderate correlation with the AHI. A lower mean FOSQ score was obtained for the group of patients with CHF and CSR-CSA (78.4 +/- 4.31 vs. 88.47 +/- 2.4; p = 0.03), showing weak negative correlation with the AHI. Conclusion: According to the MLHFQ scores, it seems that CHF patients with CSR-CSA have a worse QOL than those with CHF alone. Although this could be attributable to a greater impairment of heart function in the former group, the FOSQ scores indicate some influence of their sleep disorder on the impairment of QOL. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:646 / 651
页数:6
相关论文
共 32 条
[1]  
Arena Ross, 2002, J Cardiopulm Rehabil, V22, P273, DOI 10.1097/00008483-200207000-00010
[2]   Comparison of quality of life measures in heart failure [J].
Bennett, SJ ;
Oldridge, NB ;
Eckert, GJ ;
Embree, JL ;
Browning, S ;
Hou, N ;
Chui, M ;
Deer, M ;
Murray, MD .
NURSING RESEARCH, 2003, 52 (04) :207-216
[3]  
BONNET MH, 1992, SLEEP, V15, P526
[4]   Continuous positive airway pressure for central sleep apnea and heart failure [J].
Bradley, TD ;
Logan, AG ;
Kimoff, RJ ;
Sériès, F ;
Morrison, D ;
Ferguson, K ;
Belenkie, I ;
Pfeifer, M ;
Fleetham, J ;
Hanly, P ;
Smilovitch, M ;
Tomlinson, G ;
Floras, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (19) :2025-2033
[5]  
Brostrom Anders, 2004, J Cardiovasc Nurs, V19, P234
[6]   Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea [J].
Carmona-Bernal, C ;
Quintana-Gallego, E ;
Villa-Gil, M ;
Sánchez-Armengol, A ;
Martínez-Martínez, A ;
Capote, F .
CHEST, 2005, 127 (05) :1667-1673
[7]   Sleep disordered breathing and its treatment in congestive heart failure [J].
Cormican, LJ ;
Williams, A .
HEART, 2005, 91 (10) :1265-1270
[8]  
FELDMAN DE, 2001, CMAJ, V165, P1053
[9]  
Ferrer M, 1999, MED CLIN-BARCELONA, V113, P250
[10]   DAYTIME SLEEPINESS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE AND CHEYNE-STOKES RESPIRATION [J].
HANLY, P ;
ZUBERIKHOKHAR, N .
CHEST, 1995, 107 (04) :952-958